Multiple Reduced-intensity Conditioning Regimens Facilitate Correction of Fabry Mice After Transplantation of Transduced Cells
Authors:
Open Access
- 1 March 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (3) , 618-627
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vectorThe Lancet, 2004
- Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cellsMolecular Therapy, 2004
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cellsBlood, 2002
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- Gene therapy for Fabry diseaseJournal of Inherited Metabolic Disease, 2001
- Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cellsProceedings of the National Academy of Sciences, 2000
- Circulating alpha-Galactosidase A Derived from Transduced Bone Marrow Cells: Relevance for Corrective Gene Transfer for Fabry DiseaseHuman Gene Therapy, 1999
- Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector.Proceedings of the National Academy of Sciences, 1996
- Enzymatic Defect in Fabry's DiseaseNew England Journal of Medicine, 1967